Stocks and Investing Stocks and Investing
Wed, March 8, 2023
Tue, March 7, 2023

Judah Frommer Maintained (ATAI) at Buy with Decreased Target to $9 on, Mar 7th, 2023


Published on 2024-10-28 02:09:33 - WOPRAI, Judah Frommer
  Print publication without navigation


Judah Frommer of Credit Suisse, Maintained "Atai Life Sciences N.V." (ATAI) at Buy with Decreased Target from $11 to $9 on, Mar 7th, 2023.

Judah has made no other calls on ATAI in the last 4 months.



There are 2 other peers that have a rating on ATAI. Out of the 2 peers that are also analyzing ATAI, 0 agree with Judah's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Judah


  • Patrick Trucchio of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $20 on, Thursday, January 19th, 2023
  • Neena Bitritto-Garg of "Citigroup" Maintained at Strong Buy with Decreased Target to $10 on, Monday, January 9th, 2023
Contributing Sources